Sinequa Creates Intelligent Insight Portal to Fight COVID-19

Sinequa, a provider of intelligent search software, has created a scientific research repository and portal called COVID-19 Intelligent Insight to help in the fight against COVID-19. The free and open portal, built on Sinequa’s intelligent technology and expertise, was developed to help professionals in science and medicine rapidly sift through and analyze the numerous and evolving research on COVID-19.

Sinequa created the portal in response to the White House Office of Science and Technology Policy (OSTP) and calls from other global health organizations for “AI machine-readable technology” to address the rapidly evolving Coronavirus literature.

The portal brings together scientific papers, publications, health authority guidance, and clinical trial information into a single interface, allowing researchers to identify critical insights and analyze the vast and growing information about the COVID-19 pandemic.

“Our team was compelled to help researchers access the information they need and allow them to analyze developments or trends in scientific research about the novel Coronavirus and the related disease,” said Alexandre Bilger, CEO at Sinequa. “We are bringing together publicly available scientific data and publications and giving free access to our Intelligent Search platform and its advanced natural language processing capabilities and artificial intelligence so that researchers can find and review the emerging global evidence on the novel Coronavirus and COVID-19.”

According to Sinequa, the COVID-19 Intelligent Insight portal is one of the largest repositories of its kind, providing search and analysis of more than 70,000 papers focused on COVID-19 and SARS-CoV-2, with new material added daily. Current sources include the COVID-19 Open Research Dataset (CORD-19) of scholarly literature, papers from Elsevier, clinical studies from, and publications from the World Health Organization database and the Centers for Disease Control and Prevention (CDC).

For more information about the COVID-19 Intelligent Insight Portal, visit:

For more information about Sinequa, visit